Authors:
Anderson, PW
Cox, DA
Sashegyi, A
Paul, S
Silfen, SL
Walsh, BW
Citation: Pw. Anderson et al., Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women, MATURITAS, 39(1), 2001, pp. 71-77
Authors:
Walsh, BW
Cox, DA
Sashegyi, A
Dean, RA
Tracy, RP
Anderson, PW
Citation: Bw. Walsh et al., Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women, AM J CARD, 88(7), 2001, pp. 825
Authors:
Goldstein, SR
Scheele, WH
Rajagopalan, SK
Wilkie, JL
Walsh, BW
Parsons, AK
Citation: Sr. Goldstein et al., A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium, OBSTET GYN, 95(1), 2000, pp. 95-103
Authors:
Downs, RW
Bell, NH
Ettinger, MP
Walsh, BW
Favus, MJ
Mako, B
Wang, LX
Smith, ME
Gormley, GJ
Melton, ME
Citation: Rw. Downs et al., Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women, J CLIN END, 85(5), 2000, pp. 1783-1788
Authors:
Walsh, BW
Paul, S
Wild, RA
Dean, RA
Tracy, RP
Cox, DA
Anderson, PW
Citation: Bw. Walsh et al., The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial, J CLIN END, 85(1), 2000, pp. 214-218
Authors:
Seely, EW
Walsh, BW
Gerhard, MD
Williams, GH
Citation: Ew. Seely et al., Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women, HYPERTENSIO, 33(5), 1999, pp. 1190-1194
Authors:
Lindsay, R
Cosman, F
Lobo, RA
Walsh, BW
Harris, ST
Reagan, JE
Liss, CL
Melton, ME
Byrnes, CA
Citation: R. Lindsay et al., Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial, J CLIN END, 84(9), 1999, pp. 3076-3081
Authors:
Walsh, BW
Spiegelman, D
Morrissey, M
Sacks, FM
Citation: Bw. Walsh et al., Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol, J CLIN END, 84(3), 1999, pp. 985-989